AI Signal Dashboard
Last updated: 04.30 13:29
Top Undervalued
+37.5¢
(No)
Will Hims & Hers Health (HIMS) beat quarterly earnings? AI analysis: • +37.5¢ undervalued • Live Prediction Market fair value & mispricing alerts.
Undervalued Options Insights:
Hims & Hers (HIMS) Q1 2026 guidance was weak, with revenue ($600M-$625M) and adjusted EBITDA ($35M-$...
🔓 Log in to see more
Real-time High Yield Opportunities
View MoreAll
Outcomes
Market
Price
AI Fair
Value
Value
Edge
YesNo
85.5¢
14.5¢
48¢
52¢
0¢
+37.5¢
⚠️ Risk Warning: Live data may lag! Prices can shift instantly due to news or low liquidity. Before trading, use AI Chat for [Live Recalculate], [Check Liquidity], [Trollbox Radar], or review [Fair Value Logic] to verify.
Hedging
HIMS
The outcome of this event directly dictates the short-term price action of Hims & Hers Health (HIMS) stock. Earnings beats or misses typically trigger significant gap up/down volatility for growth stocks (often >10%), warranting a high impact score. However, due to the company's relatively small market cap, it has no meaningful spillover effects on broader market indices.